REVIEW ARTICLE Advances in pathophysiology of arterial hypertension 195 population. Notably, only 46.5% of participants were aware of their hypertension, with less than half (40.6%) medically treated and BP levels less than 140/90 mm Hg achieved in 1 in 3 individuals (13.2%).1 The global disparities in the prevalence, awareness, treatment, and control of hypertension have also been indicated in a recent meta -analysis of 135 population -based studies from 90 countries.2 Globally, the number of individuals with hypertension increased, reaching an estimated total of 1.39 billion adults with hypertension, including 349 million in high -income countries and 1.04 billion in low-and middle -income countries by 2010. The increased and highest prevalence of raised BP has been particularly noted in East Europe, Asia, Africa, and Latin America. 2 Introduction Despite the well -recognized benefits of reducing major cardiovascular events and mortality through the control of blood pressure (BP), detection rates and control of hypertension remain low across all countries. Even though therapy is initiated in the vast majority of patients diagnosed with hypertension, treatment is suboptimal with a declined use of antihypertensive drugs over time. A large gap between the prevalence, awareness, treatment, and control of hypertension has been addressed in the multinational Prospective Urban Rural Epidemiology (PURE) study conducted in 628 communities, including high -income, upper -middle -income, low -middle -income and low -income countries.
KEY WORDShypertension, interventional therapies, neural reflexes, neuroplasticity, sympathetic nervous system ABSTRACT Hypertension remains a major and growing public health problem associated with the greatest global rate of cardiovascular morbidity and mortality. Although numerous factors contribute to poor control of blood pressure (BP) and to pseudo resistance (eg, unawareness, lifestyle habits, nonadherence to medication, insufficient treatment, drug -induced hypertension, undiagnosed secondary causes), true resistant hypertension (RH) is reported in 10.1% of patients treated for elevated BP. While the mechanisms underlying RH remain complex and not entirely understood, sympathetic activation involved in the pathophysiology of hypertension, disease progression, and adverse complications is further augmented in patients with drug -resistant hypertension. The well -established contribution of neurogenic component of hypertension has led to the introduction of new alternative therapies aimed specifically at modulating central and neural reflexes mechanisms involved in BP control. Although clinical benefits of lowering BP with renal denervation, baroreflex activation therapy, carotid body denervation, central arteriovenous anastomosis, and deep brain stimulation have advanced our knowledge on uncontrolled hypertension, the variable BP response has prompted extensive ongoing research to define predictors of treatment effectiveness and further investigation of pathophysiology of RH. Very rec...